Cell Culture
03 July 2013 - 04 July 2013
Cell culture is set to see huge increases in growth including the recent advances in techniques such as 3D cell culture. The cell culture market is set to be worth £4.5 billion by 2020 driven by advances in pharma and biotech. Over the two day conference delegates will be exposed to leading decision makers in a range Cell Culture related fields from Europe and the States, listen to our keynote speakers on day one speak about the latest data coming back from culture techniques being used on the International Space Station.
Day one will focus on the recent advances in 3D cell culture. Case studies will demonstrate how this method is providing highly physiologically accurate preclinical data and current approaches for culture in relevant diseases.
Day two's speaking faculty will focus on cell culture process development and cell line development including the use of high throughput technologies.
Copthorne Tara Hotel, Kensington, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/conference/cell-culture?utm_source=P-046&utm_medium=EM%20-%20RM&utm_campaign=GroupMail
Paediatric Drug Development
08 July 2013
This uniquely interactive full day masterclass will present attendees with an indepth overview into the practical aspects of pediatric
drug development alongside efficient and effective methods to overcome challenges faced. The event, led by the expertise and experience of Dr. Klaus Rose, Managing Director, klausrose Consulting, will provide a focus on: pediatric clinical trials, legislation considerations, Pediatric Investigation Plan (PIP) and the impact of the pediatric legislation in both US and EU. The event will also act as an ideal platform for problem solving, debate and discussion into key obstacles facing the pediatric drug development process.
Holiday Inn London-Bloomsbury , London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/masterclass/pediatric-drug-development?utm_source=MC306&utm_medium=EM%20-%204S&utm_campaign=GroupMail
11th Vaccines Research and Development: All Things Considered
08 July 2013 - 10 July 2013
Development of new vaccines truly requires a consideration of many things. We examine vaccine development from basic research to marketing. We bring together the people who make the discoveries, make the decisions, fund the work and license the vaccines and foster their interaction with the attendees to share their perspectives of the vaccine industry. The latest information on the new malaria, HIV, tumor, and therapeutic vaccines, DNA vaccines, RNA vaccines, adjuvants, mucosal and other delivery mechanisms will be presented, as will updates on governmental priorities, funding and partnership opportunities. Representatives from the HHS, BARDA and NIH as well as NGO will provide a first-hand perspective into current US vaccines policy, regulation and funding as well as updates on the pandemic and bio-defense policy. All aspects from discovery to marketing will be covered.
Westin Copley Place Boston Hotel, Boston, MA, USA
http://www.gtcbio.com/index.php?option=com_conference&file=home&cn=11th%20Vaccines%20Research%20and%20Development:%20All%20Things%20Considered&cid=48
8th Protein Kinases in Drug Discovery Conference
08 July 2013 - 09 July 2013
GTCbio is proud to present our 8th Protein Kinases in Drug Discovery Conference! This meeting will be held July 8-9, 2013 at the Westin Copley Place Boston Hotel in historical Boston, Massachusetts, one of the most concentrated academic and industrial areas in the United States. We will bring together industry leaders from major pharmaceutical companies, biotech companies as well as top researchers from academia and government to provide you with a better understanding of the complex activities of kinases and some solutions to the challenges associated with kinase drug development.
Westin Copley Place Boston Hotel, Boston, MA, USA
http://www.gtcbio.com/component/conference/?file=home&cn=8th+Protein+Kinases+in+Drug+Discovery&cid=24&utm_source=3rdparty&utm_medium=eventlisting&utm_campaign=8pkdd